A detailed history of Financial Advocates Investment Management transactions in Abbott Laboratories stock. As of the latest transaction made, Financial Advocates Investment Management holds 12,304 shares of ABT stock, worth $1.41 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
12,304
Previous 12,085 1.81%
Holding current value
$1.41 Million
Previous $1.26 Million 11.71%
% of portfolio
0.08%
Previous 0.08%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$100.07 - $118.13 $21,915 - $25,870
219 Added 1.81%
12,304 $1.4 Million
Q2 2024

Jul 26, 2024

SELL
$100.73 - $112.44 $72,324 - $80,731
-718 Reduced 5.61%
12,085 $1.26 Million
Q1 2024

May 01, 2024

BUY
$109.52 - $120.96 $80,497 - $88,905
735 Added 6.09%
12,803 $1.46 Million
Q4 2023

Feb 08, 2024

SELL
$90.19 - $110.4 $449,056 - $549,681
-4,979 Reduced 29.21%
12,068 $1.33 Million
Q3 2023

Oct 27, 2023

BUY
$95.53 - $114.62 $12,418 - $14,900
130 Added 0.77%
17,047 $1.65 Million
Q2 2023

Aug 07, 2023

SELL
$100.78 - $112.29 $9,574 - $10,667
-95 Reduced 0.56%
16,917 $1.84 Million
Q1 2023

May 11, 2023

SELL
$96.86 - $114.01 $30,801 - $36,255
-318 Reduced 1.83%
17,012 $1.72 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $592,604 - $695,215
6,234 Added 56.18%
17,330 $1.9 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $516,311 - $597,792
-5,336 Reduced 32.47%
11,096 $1.07 Million
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $243,130 - $293,867
2,382 Added 16.95%
16,432 $1.79 Million
Q1 2022

May 11, 2022

BUY
$114.02 - $139.04 $93,268 - $113,734
818 Added 6.18%
14,050 $1.66 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $540,449 - $661,749
4,678 Added 54.69%
13,232 $1.86 Million
Q3 2021

Nov 04, 2021

BUY
$116.66 - $129.06 $14,815 - $16,390
127 Added 1.51%
8,554 $1.01 Million
Q2 2021

Aug 03, 2021

BUY
$105.79 - $124.53 $116,263 - $136,858
1,099 Added 15.0%
8,427 $977,000
Q1 2021

May 10, 2021

SELL
$108.84 - $128.23 $23,291 - $27,441
-214 Reduced 2.84%
7,328 $878,000
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $85,365 - $93,023
813 Added 12.08%
7,542 $825,000
Q3 2020

Nov 04, 2020

SELL
$91.64 - $111.29 $52,601 - $63,880
-574 Reduced 7.86%
6,729 $732,000
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $84,686 - $108,388
1,106 Added 17.85%
7,303 $667,000
Q1 2020

Apr 29, 2020

SELL
$62.82 - $91.86 $30,216 - $44,184
-481 Reduced 7.2%
6,197 $489,000
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $66,419 - $73,940
846 Added 14.51%
6,678 $580,000
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $89,532 - $97,081
-1,094 Reduced 15.8%
5,832 $488,000
Q2 2019

Aug 08, 2019

BUY
$72.88 - $85.0 $63,041 - $73,525
865 Added 14.27%
6,926 $583,000
Q1 2019

May 16, 2019

BUY
$66.22 - $80.06 $93,105 - $112,564
1,406 Added 30.2%
6,061 $485,000
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $62,347 - $70,630
-951 Reduced 16.96%
4,655 $336,000
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $48,222 - $58,174
793 Added 16.48%
5,606 $0
Q2 2018

Aug 09, 2018

SELL
$57.57 - $63.54 $5,699 - $6,290
-99 Reduced 2.02%
4,813 $293,000
Q1 2018

May 11, 2018

BUY
$56.27 - $63.62 $15,699 - $17,749
279 Added 6.02%
4,912 $294,000
Q4 2017

Feb 15, 2018

BUY
$53.68 - $57.47 $248,699 - $266,258
4,633
4,633 $264,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Financial Advocates Investment Management Portfolio

Follow Financial Advocates Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advocates Investment Management with notifications on news.